Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

CARDIAC TRANSPLANTATION ANNUAL REVIEW OF MEDICINE Hunt, S. A., Stinson, E. B. 1981; 32: 213-220

Abstract

Based on the Stanford series of 188 patients, we emphasize that orthotopic cardiac transplantation represents a reasonable therapeutic option for the patient with inoperable end-stage heart disease. Current expectations for survival equal those for organ survival in cadaver renal transplant series and offer a rehabilitation potential of over 90%. Most of the complications limiting survival are due to the currently available means of immunosuppression and, therefore, advances in the field of immunosuppression can be expected to have a major positive influence on survival rates.

View details for Web of Science ID A1981LH58600016

View details for PubMedID 7013663